Skip to main content
. 2021 Jun 11;32(2):313–322. doi: 10.52312/jdrs.2021.72

Table 1. The callus volume/bone volume ratio and BMD measured by microcomputed tomography at two and six weeks in the control, V5 (Vardenafil 5 mg) and V10 (Vardenafil 10 mg) groups.

  2nd week 6th week p value
Mean±SE Mean±SE
Callus volume/bone volume (mm3/mm3)      
Control group 1.41±0.22 0.69±0.05† 0.0022
V5 group 1.35±0.11 0.79±0.06*,† 0.0022
V10 group 1.42±0.15 0.80±0.04*,† 0.0043
p value 0.964 0.022  
BMD (g/cm3)      
Control group 0.949±0.013 1.051±0.004† 0.0022
V5 group 0.974±0.009 1.051±0.008† 0.0022
V10 group 0.957±0.013 1.058±0.006† 0.0022
p value 0.373 0.665  
BMD: Bone mineral density; SE: Standard error; * p<0.05 vs control group; † p<0.01 vs 2nd week group.